Heidelberg University
Clinical trials sponsored by Heidelberg University, explained in plain language.
-
Heart drug study for rare lung disease stopped early
Disease control TerminatedThis study looked at whether the drug riociguat could reduce the size of the right side of the heart in people with two types of high blood pressure in the lungs (pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension). The study planned to enroll 30 ad…
Phase: PHASE4 • Sponsor: Heidelberg University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Lung pressure drug trial halted early
Disease control TerminatedThis study tested a drug called riociguat in people with early pulmonary vascular disease, a condition where blood vessels in the lungs are under too much pressure. The goal was to see if the drug could improve blood flow and heart function. The study included 35 adults with conn…
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC